Mirati Therapeutics reported $42.92M in Trade Creditors for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
Acceleron Pharma XLRN:US $ 5.09M 4.35M
Agios Pharmaceuticals AGIO:US $ 10.31M 2.65M
Alnylam Pharmaceuticals ALNY:US $ 40.05M 13.03M
Amgen AMGN:US $ 1171M 106M
Astellas Pharma 4503:JP Y 111568M 3115M
Bayer BAYN:GR 5.59B 469M
Bluebird Bio BLUE:US $ 21.67M 17.63M
Bristol Myers Squibb BMY:US $ 2695M 914M
Eisai 4523:JP Y 76277M 4499M
Eli Lilly And LLY:US $ 1566.8M 31M
Exelixis EXEL:US $ 24.31M 3.86M
Moderna Inc MRNA:US 87M 10M
Nektar Therapeutics NKTR:US $ 23.66M 3.96M
Novartis NOVN:VX 4.66B 146M
Puma Biotechnology PBYI:US $ 20.05M 8.88M
Sarepta Therapeutics SRPT:US $ 44.16M 32.52M
Seattle Genetics SGEN:US $ 109.96M 7.55M
Spectrum Pharmaceuticals SPPI:US $ 40.91M 0.95M
Takeda 4502:JP Y 336600M 15955M
Ultragenyx Pharmaceutical RARE:US $ 15.58M 6.22M
YTE INCY:US $ 114.51M 7.59M